ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Lincoln Pharmaceuticals announced the resignation of Mr. Manoj Rai, Sr. General Manager (Head QA), a Senior Management Personnel. He departs effective 24 September 2026 for personal reasons.
Lincoln Pharmaceuticals has dispatched physical letters to shareholders with unregistered email IDs to provide access to the Annual Report for FY 2025-26 and facilitate KYC updates.
Lincoln Pharmaceuticals submitted its Annual Report for FY 2025-26 and notice for the 32nd Annual General Meeting scheduled for September 30, 2026.
Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹177.3 Cr (+15.1% YoY) and net profit of ₹36.2 Cr (+30.7% YoY) for Q1 FY27.
Lincoln Pharmaceuticals Ltd reported revenue from operations of ₹187.3 Cr (+11.4% YoY) and net profit of ₹11.6 Cr (+0.0% YoY) for Q4 FY26.